Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 40 (4) , 337-350
- https://doi.org/10.1016/0090-6980(90)90099-h
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Endothelin-1 Releases Eicosanoids from Rabbit Isolated Perfused Kidney and SpleenJournal of Cardiovascular Pharmacology, 1989
- Pharmacology of Endothelin-1 in Isolated VesselsJournal of Cardiovascular Pharmacology, 1989
- Endothelin-1Journal of Cardiovascular Pharmacology, 1989
- Endothelin-1-Induced Vascular ContractionsJournal of Cardiovascular Pharmacology, 1989
- The Discovery, the Present State, and the Future Prospects of EndothelinJournal of Cardiovascular Pharmacology, 1989
- Nonsteroidal Antiinflammatory Drugs Aggravate Acute Myocardial Ischemia in the Perfused Rabbit HeartJournal of Cardiovascular Pharmacology, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Endothelial cells in culture produce a vasoconstrictor substanceJournal of Cellular Physiology, 1987
- Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heartEuropean Journal of Pharmacology, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980